{"disease":{"id":"basal-cell-carcinoma-of-skin","name":"Basal cell carcinoma of skin","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"erismodegib","indication_name":"Basal cell carcinoma of skin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Erismodegib","company_name":"Washington University School of Medicine","drug_phase":"discontinued","molecular_target":"Smoothened homolog, Sonic hedgehog protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"vismodegib","indication_name":"Basal cell carcinoma of skin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Erivedge","generic_name":"vismodegib","company_name":"Roche","drug_phase":"marketed","molecular_target":"Smoothened","drug_class":"Hedgehog Pathway Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Vismodegib inhibits the Hedgehog pathway by binding to and blocking Smoothened, a key protein in the pathway."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02310503","title":"Spanish Registry of Mohs Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fundación Academia Española de Dermatología","has_results":false},{"nct_id":"NCT03621462","title":"Elucid Labs AIDA™ - Labelled Image Acquisition Protocol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Elucid Labs Inc.","has_results":false},{"nct_id":"NCT06661577","title":"An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of Auckland, New Zealand","has_results":false},{"nct_id":"NCT07347392","title":"The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2900,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07361666","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","has_results":false},{"nct_id":"NCT07501780","title":"Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05188729","title":"Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03534947","title":"A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Melanoma Institute Australia","has_results":false},{"nct_id":"NCT04480645","title":"CivaDerm(TM) Surface Therapy Pilot Study","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"CivaTech Oncology","has_results":false},{"nct_id":"NCT07428941","title":"Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"AI Labs Group S.L","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}